Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Clin Cancer Res. 2021 Feb 16;27(9):2604–2612. doi: 10.1158/1078-0432.CCR-20-4772

Figure 3. Analysis of somatic mutational signatures in KRAS-mutant tumors.

Figure 3.

Comparison of the relative frequencies of 8 detectible mutational signatures between the KRASG12C and other KRAS mutation (KRASother) groups, and proposed etiologies for these signatures.